Cite

HARVARD Citation

    Keating, M. et al. (2019). Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer. Journal of oncology pharmacy practice. pp. 1927-1932. [Online]. 
  
Back to record